This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Feb 15;21(4):580-2.

doi: 10.1200/JCO.2003.10.085.

Combination chemotherapy for metastatic breast cancer: reaching for the cure

PMID: 12586790
DOI: 10.1200/JCO.2003.10.085

Review

Combination chemotherapy for metastatic breast cancer: reaching for the cure

Beth Overmoyer. J Clin Oncol. 2003.

. 2003 Feb 15;21(4):580-2.

doi: 10.1200/JCO.2003.10.085.

Author

PMID: 12586790
DOI: 10.1200/JCO.2003.10.085

No abstract available

PubMed Disclaimer

Comment on

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC. Sledge GW, et al. J Clin Oncol. 2003 Feb 15;21(4):588-92. doi: 10.1200/JCO.2003.08.013. J Clin Oncol. 2003. PMID: 12586793 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information